Breast Care

Papers
(The median citation count of Breast Care is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Kombinationstherapie bei HER2+ mBC58
How Can Oncoplastic Breast Surgery Contribute to the Management of Locally Advanced Breast Cancer in Sub-Saharan Africa?33
PharmaNews25
St. Gallen/Vienna 2025 Summary of Key messages on therapy in Early Breast Cancer from the 2025 St. Gallen International Breast Cancer Conference (SGBCC)24
Front & Back Matter19
Acknowledgement to Reviewers19
Influence of Breast Reduction Surgery on Long-Term Breast Cancer Risk in Austria18
Predictors for Upgrade to Breast Cancer in Patients with B3 Lesions Diagnosed by Core Biopsy: A Retrospective Cohort Study17
Comparing the Efficacy of Intralesional Injection versus Systemic Steroids in Treating Idiopathic Granulomatous Mastitis: Insights from a Single-Center Experience16
Effects and Risks of Hormonal Therapy before and after BC Therapy12
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation12
Nationwide Survey of German Outpatient Gynecologic Oncology Practices during the Coronavirus Disease 2019 Pandemic: Reactions to the First Wave and Future Perspectives12
Front & Back Matter11
Targeted Axillary Dissection after Chemotherapy: Feasibility Study with Clip and Carbon Dye Tattoo – Neotarget Trial11
Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis10
Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study10
Impact of the National Action Plan for Antimicrobial Resistance on Antibiotic Use for Mastitis Using a Japanese Nationwide Database10
Interview ABC7: Bridging the Gap8
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases8
PharmaNews8
Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2− Breast Cancer Patients8
Sacituzumab govitecan: Trop-2 als Target8
Quality of Life in Patients Pre- and Post-Breast Reduction Surgery in a South African Population: a single-centred patient-based study8
Quality of Life after Alloplastic versus Autologous Breast Reconstruction: The Influence of Patient Characteristics on Outcomes7
Ten-Year Survival of Breast Cancer in Iran: A National Study (Retrospective Cohort Study)7
Tamoxifen Treatment for Pubertal Gynecomastia: When to Start and How Long to Continue7
Factors Indicating Surgical Excision in Classical Type of Lobular Neoplasia of the Breast7
Evolution of HER2 Targeting in Metastatic Breast Cancer6
Front & Back Matter6
Primary Prevention and Early Detection of Hereditary Breast Cancer6
Large-Scale Population Screening for BRCA1 and BRCA2 Ashkenazi Founder Mutations: Perspectives of Professionals Providing Oncogenetic Consultations5
Clinicopathological Factors Affecting Positive Margins after Breast-Conserving Surgery: A Comparative Study of Low- and High- Volume Hospitals.5
Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection5
Effectiveness of Peer Support on Quality of Life and Anxiety in Breast Cancer Patients: A Systematic Review and Meta-Analysis4
Is 9-G DBT-Guided Vacuum-Assisted Breast Biopsy Sufficient to Completely Remove T1 Breast Cancers (below 20 mm)? Analysis of 146 Patients with Histology as Reference Standard4
Analysis of lifestyle and genetic risk factors in urban women in China who had malignant or suspected malignant breast nodules identified via breast cancer screening4
First-Line Efficacy of Anti-HER2 Treatments in Previously Treated HER2-Positive Metastatic Breast Cancer Patients: A Retrospective Observational Study Investigating the Efficacy of Re-Exposure to Anti4
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response4
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes4
Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer3
Acknowledgement to Reviewers3
Non-Surgical Site Pain in Women following Breast Cancer Surgery: A Systematic Review and Meta-Analysis3
37. Annual Meeting of the Austrian Society of Senology. Vienna, Austria, Sept. 8–9 2023. Abstracts3
Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study3
Malignancy Rate and Malignancy Risk Assessment in Different Lesions of Uncertain Malignant Potential in the Breast (B3 Lesions): An Analysis of 192 Cases from a Single Institution3
Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience3
Expert Discussion: SABCS 20213
Quality Analysis of YouTube Videos Presenting Shoulder Exercises after Breast Cancer Surgery3
Banana Supplementation for Breast Cancer Surgery Patients: A Two-Center Experience3
Revisiting the Need for Breast Imaging in Young Women with Clinically Significant Breast Pain and a Normal Physical Breast Examination3
Society Bulletins3
Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions3
Keeping a Breast with Social Media: “Le Marteau Sans Maître?”3
Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS)3
<i>TP53</i> Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy3
Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer3
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in Belgium2
Evaluation of Interreader Agreement between Optimized Short and Full Breast MRI Protocols for Screening Breast Cancer in Moderate- and High-Risk Women2
Biomarkers: Which Ones Do We Really Need Today?2
Cost-Effectiveness Analysis of Abemaciclib plus Fulvestrant versus Placebo plus Fulvestrant in Patients with Hormone Receptor-Positive, ERBB2-Negative Breast Cancer2
Menopausal Hormone Therapy and the Breast: A Review of Clinical Studies2
Are Diagnostic Delays Associated with Distress in Breast Cancer Patients?2
Review Article a Multidisciplinary Evaluation for Advanced Supportive Care of Breast Cancer Patients2
Comparison of Intermittent Pneumatic Compression Pump as Adjunct to Decongestive Lymphatic Therapy against Decongestive Therapy Alone for Upper Limb Lymphedema after Breast Cancer Surgery: A Systemati2
Oncoplastic Breast Conserving Surgery: Is There a Need for Standardization? Results of a Nationwide Survey2
Natural Language Processing to Extract Meaningful Information from a Corpus of Written Knowledge in Breast Cancer: Transforming Books into Data2
Insights from ASCO 20232
Translating Evidence into Practice: A Review of Clinical Practice and Outcomes following the Adoption of an Early Post-Mastectomy Discharge Protocol in a Nigerian Hospital2
Pushing the Limits of Breast-Conserving Surgery with Extreme Oncoplasty2
Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level2
PharmaNews2
Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries2
PharmaNews2
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20252
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC Consensus2
Targeted Axillary Dissection Using Surgical Marker Navigation after Neoadjuvant Systemic Treatment in Breast Cancer Patients: A Single-Center Experience2
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20242
The Evolution of Educational Events during the COVID-19 Pandemic: The Experience of G.Re.T.A. Foundation2
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib2
Front & Back Matter2
PharmaNews1
Acupuncture for Aromatase Inhibitor-Induced Arthralgia in Breast Cancer: An Umbrella Review1
ADC-basierte Therapie und Radiatio1
Augmented Reality in Breast Surgery Education1
Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer1
Front & Back Matter1
Hormone Receptor and HER2 Status Switch in Non-pCR Breast Cancer Specimens after Neoadjuvant Therapy1
Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts1
News from the San Antonio Breast Cancer Symposium 20221
Expert Discussion: ESMO 20241
PharmaNews1
Prepubertal Idiopathic Unilateral Gynecomastia: Case Report and Literature Review1
Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy1
Contents Vol. 18, 20231
New Media Platforms for Teaching and Networking: Emerging Global Opportunities for Breast Surgeons1
Ärzt*in-Patient*in-Perspektive: Rezidivrisiko bei Brustkrebs1
PharmaNews1
Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?1
Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants1
HER2-Low Breast Cancer: Where Are We?1
Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis1
Contents Vol. 19, 20241
PharmaNews1
Investigation of Risk Factors and Development and Validation of a Nomogram for Predicting Overall Survival in Breast-Invasive Lobular Carcinoma1
Brain metastases of a triple-negative breast cancer – A systematic literature review of the systemic treatment options1
Contents Vol. 17, 20221
Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer1
St. Gallen/Vienna 2023: Optimization of Treatment for Patients with Primary Breast Cancer – A Brief Summary of the Consensus Discussion1
Endocrine Therapy: From Ovarian Ablation to Individualized Therapy and Signal Inhibition1
Phyllodes Tumor of the Breast: Histomorphological Transformation to High-Grade Tumor during Pregnancy and Challenging Oncoplastic Surgery1
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer1
Vitamin D and Breast Cancer Risk: Evaluating the Association and Effective Risk Reduction1
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20231
Physicians’ Perception of the Evidence in Relation to Primary Endpoints of Clinical Trials on Breast Cancer0
Gonadotropin-Releasing Hormone Agonists during Gonadal Chemotherapy for the Effect on Pregnancy Outcome and Ovarian Function in Premenopausal Patients with Breast Cancer: A Systematic Review and Meta-0
Highlights from the San Antonio Breast Cancer Symposium 20240
Treatment Options for Early Stage Inoperable Breast Cancer: Cryoablation or Radiotherapy?0
Evaluation of Patient Satisfaction and Quality of Life Using the BREAST-Q Questionnaire in Oncoplastic Breast-Conserving Surgery Techniques for Centrally Located Breast Cancer0
Breast Cancer Outcome: What Have We Achieved0
Front & Back Matter0
Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?0
Pyoderma gangrenosum of the breast: a diagnostic challenge0
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20220
Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study0
Moderate Intensity Exercise Reduces Side Effects of Cancer Therapy and Maintains Cardiorespiratory Fitness in Male Breast Cancer Patients: Findings from the BRECA Male Crossover Study0
App-Based Lifestyle Coaching (PINK!) Accompanying Breast Cancer Patients and Survivors to Reduce Psychological Distress and Fatigue and Improve Physical Activity: A Feasibility Pilot Study0
PharmaNews0
Front & Back Matter0
Recommendation and Acceptance of Counselling for Familial Cancer Risk in Newly Diagnosed Breast Cancer Cases0
Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study0
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative R0
Acknowledgement to Reviewers0
Erratum0
Trastuzumab-Deruxtecan: Neue Ära bei HER2-low mBC0
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20220
The Role of High Intensity Focused Ultrasound in the Treatment of Fibroadenomas: A Systematic Review0
Phytoestrogen Treatment for Menopausal Vasomotor Symptoms after Breast Cancer0
Ultrasound Measurement of the Distance between the Breast Tumor and the Skin: A Cut-Off Value for Safe Skin Preservation – Diagnostic Accuracy Study0
Sacituzumab Govitecan – hoch effektiv0
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20230
Prediction of Cardiac Toxicity by Measurement of Coronary Artery Calcium Scoring Method Using Chest Computed Tomography in Early Breast Cancer Patients Treated with Trastuzumab0
THREE FRACTION EXTERNAL BEAM RADIOTHERAPY IN PATIENTS WITH EARLY BREAST CANCER0
Diagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report0
Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis0
Breast-Conserving Surgery with Immediate Partial Breast Reconstruction by Using Pedicled Thoracodorsal Artery Perforator Flap: A 7-Year Follow-Up of 50 Women0
PharmaNews0
PharmaNews0
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference0
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20240
Evaluating HEmopatch® in Reducing Seroma-Related Complications following Axillary Lymph Node DIssection: A Pilot Study (HEIDI)0
PharmaNews0
ABC6 Consensus: Assessment by a Group of German Experts0
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 20180
Evaluation of the Effect of Axillary Radiotherapy Dose and the Development of Lymphedema in Breast Cancer Patients0
Use of the Gene Expression Test Prosigna<sup>®</sup> in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-670
Lymph Node Pathologic Complete Response Rates in Breast Cancer Patients After Neoadjuvant Chemotherapy: Is Axillary Sampling Necessary?0
Society Bulletins0
A Preliminary Study of Ultrasound-Guided Microwave Ablation for Nonpuerperal Mastitis Treatment0
Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences0
Prognostic Importance of Panimmune-Inflammation Value and PILE Scores in Non-Metastatic Luminal A Breast Cancer0
Front & Back Matter0
Routine Preoperative Nutritional Optimization Not Required in Patients Undergoing Breast Reconstruction0
Do we need the anthracyclines for elderly patients with triple negative breast cancer?0
First-in-Class-Therapie mit Sacituzumab Govitecan0
Granulomatous Mastitis is not as benign as you might think. What doctors need to know about the lived experience of people with this rare disease.0
Predicting Survival of Patients with Nonmetastatic Breast Cancer Based on Fibrinogen-to-Albumin Ratio and Lymphocyte-to-Monocyte Ratio: A Nomogram-Based Assessment0
ABC7 Consensus: Assessment by a German Group of Experts0
The Impact of Breast Awareness on the Early Detection of Breast Cancer in Young Women: A Systematic Review0
The Role of Social Media in Breast Cancer Care and Survivorship: A Narrative Review0
Retrospective Impact of COVID-19 Pandemic on Primary Breast Cancer Care0
Front & Back Matter0
Mammakarzinom: Phesgo im häuslichen Umfeld0
Magnetic Marker Artefacts on MRI and Localization Precision: Considerations for Targeted Axillary Dissection after Neoadjuvant Therapy0
Intention to Undergo Clinical Breast Examination and Its Associated Factors among Women Attending Rural Primary Healthcare Facilities in South Central Ethiopia0
Front & Back Matter0
Axillary surgical management in breast cancer patients after neoadjuvant systemic therapy: a Delphi Study0
Prognostic Impact of Immunophenotypic Variation in Subcapsular Sinus Endothelium of Sentinel Lymph Nodes in Invasive Breast Carcinoma0
Expert Discussion: ASCO 20220
Impact of Diabetes on Patient Outcomes in Breast Cancer Patients0
PharmaNews0
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer0
The Ongoing Necessity of Sentinel Lymph Node Biopsy for cT1–2N0 Breast Cancer Patients0
Front & Back Matter0
A Second Ductoscopy Procedure in Patients with Recurrent and Persistent Pathological Nipple Discharge0
Expert Discussion: Hypofractionated Radiation Therapy – Standard for All Indications?0
ASCO 2024: Personal Insights and a Look into the Future from an International Expert Group0
The Role of Social Media and Breast Cancer: How Does It Impact Patients?0
Patient Preferences for HR+/HER2− Early Breast Cancer Adjuvant Treatment: A Multicountry Discrete Choice Experiment0
Clinical Importance of PGRMC1 in Hormone Responsive Breast Cancer0
Budget Impact of the Oncotype DX Breast Recurrence Score<sup>®</sup> Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany0
Strict versus Liberal Use of Sentinel Node Biopsy in Breast Cancer Surgery: Any Clinical Outcome Differences? A 20-Year Clinical Experience0
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors0
PharmaNews0
Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Muta0
What Has Changed in Patients Aged 65 and over Diagnosed with Breast Cancer during the COVID-19 Pandemic: A Single-Center Experience0
Risk Factors for Idiopathic Granulomatous Mastitis Recurrence after Patient-Tailored Treatment: Do We Need an Escalating Treatment Algorithm?0
CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis0
Online Training to increase genetic and risk literacy in physicians counseling breast and ovarian cancer patients for genetic testing0
Erratum0
PharmaNews0
Risk and Survival of Third Primary Cancers in a Population-Based Cohort of Breast Cancer Patients0
Clinicopathologic Features and Pathogens of Granulomatous Lobular Mastitis0
PharmaNews0
A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer0
Breast Augmentation with Autologous Fat Grafting Immediately after Removal of Polyacrylamide Hydrogel and Fibrotic Capsule in 162 Patients0
Associated Factors with Breast Nurses Unplanned Interventions in Patients Treated for an Early Breast Cancer0
Society Bulletins0
The Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study0
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 20250
Erratum0
Idiopathic Granulomatous Mastitis: A Consensus Report on Treatment and Follow-Up Approaches Based on the Turkish Clinical Classification0
Clinical Outcomes in Breast Cancer Patients with HER2-Positive, Node-Negative Tumors (≤3 cm)0
Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period0
Clinical Axillary Staging in Breast Cancer Patients Using Ultrasound Imaging0
PharmaNews0
Long-Term Outcome Analysis and Technical Refinements after Autologous Breast Reconstruction with PAP Flap: What We Have Learnt0
PharmaNews0
Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer0
Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers0
Fokus-Änderung auf HER2-Status beim mBC0
The Role of 18F-FDG PET/CT in Predicting the Neoadjuvant Treatment Response in Patients with Locally Advanced Breast Cancer0
A Response and Discussion with Respect to Gulcelik’s Study in Oncoplastic Level II Surgical Techniques for Breast Cancer Treatment0
Management von Antikörper-Wirkstoff-Konjugaten bei mBC0
Patient-Reported Outcomes in Free-Flap Breast Reconstructive Surgery over Time (PRO-BREST)0
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer0
PharmaNews0
CDK4/6-Inhibitoren: Neue Daten vom ESMO und ASCO0
Clinicopathological features, surgical outcomes and microbial patterns in chronic granulomatous mastitis: A retrospective study from a public hospital in Lima, Peru.0
The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy0
Primary Breast Sarcoma: A Two-Centre Analysis and Review of Literature0
Exploring the Impact of Sarcopenia on Mortality in Breast Cancer Patients: A Comprehensive Systematic Review and Meta-Analysis0
PharmaNews0
A Decade of AGO QS-Mamma: Adherence to the Recommendations of the AGO Breast Committee for Diagnosis and Treatment in EBC in Routine Therapy in Germany0
Palbociclib: Neue 5-Jahres-OS-Daten aus RCT bei HR+/HER2– aBC0
Risk assessment using gene expression profiling correlates with clinical prognosis estimation in hormone receptor-positive/HER2-negative early breast cancer0
Patient Satisfaction, Esthetic Outcome, and Quality of Life in Oncoplastic and Reconstructive Breast Surgery: A Single Center Experience0
Current Evolutions in Axillary Management0
0.11395502090454